Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer

被引:5
作者
Yagyu, Takuki [1 ,2 ]
Ohira, Takahito [2 ,3 ]
Shimizu, Ryutaro [2 ,4 ]
Morimoto, Masaki [1 ]
Murakami, Yuki [1 ]
Hanaki, Takehiko [1 ]
Kihara, Kyoichi [1 ]
Matsunaga, Tomoyuki [1 ]
Yamamoto, Manabu [1 ]
Tokuyasu, Naruo [1 ]
Sakamoto, Teruhisa [1 ]
Fujiwara, Yoshiyuki [1 ]
Kugoh, Hiroyuki [2 ,3 ]
机构
[1] Tottori Univ, Div Gastrointestinal & Pediat Surg, Sch Med, Fac Med,Dept Surg, Yonago, Tottori, Japan
[2] Tottori Univ, Div Genome & Cellular Funct, Dept Mol & Cellular Biol, Yonago, Tottori, Japan
[3] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan
[4] Tottori Univ, Div Urol, Dept Surg, Fac Med, Yonago, Tottori, Japan
基金
日本学术振兴会;
关键词
TUMOR-SUPPRESSOR GENES; TELOMERASE; DELETIONS; MUTATIONS; CELLS; LUNG; PATHOGENESIS;
D O I
10.1038/s41598-021-94711-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Frequent loss of heterozygosity (LOH) on the short arm of human chromosome 3 (3p) region has been found in pancreatic cancer (PC), which suggests the likely presence of tumor suppressor genes in this region. However, the functional significance of LOH in this region in the development of PC has not been clearly defined. The human telomerase reverse transcriptase gene (hTERT) contributes to unlimited proliferative and tumorigenicity of malignant tumors. We previously demonstrated that hTERT expression was suppressed by the introduction of human chromosome 3 in several cancer cell lines. To examine the functional role of putative TERT suppressor genes on chromosome 3 in PC, we introduced an intact human chromosome 3 into the human PK9 and murine LTPA PC cell lines using microcell-mediated chromosome transfer. PK9 microcell hybrids with an introduced human chromosome 3 showed significant morphological changes and rapid growth arrest. Intriguingly, microcell hybrid clones of LTPA cells with an introduced human chromosome 3 (LTPA#3) showed suppression of mTert transcription, cell proliferation, and invasion compared with LTPA#4 cells containing human chromosome 4 and parental LTPA cells. Additionally, the promoter activity of mTert was downregulated in LTPA#3. Furthermore, we confirmed that TERT regulatory gene(s) are present in the 3p21.3 region by transfer of truncated chromosomes at arbitrary regions. These results provide important information on the functional significance of the LOH at 3p for development and progression of PC.
引用
收藏
页数:10
相关论文
共 46 条
  • [1] Abe Satoshi, 2010, Genome Integr, V1, P6, DOI 10.1186/2041-9414-1-6
  • [2] Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma
    Alimov, A
    Kost-Alimova, M
    Liu, J
    Li, CD
    Bergerheim, U
    Imreh, S
    Klein, G
    Zabarovsky, ER
    [J]. ONCOGENE, 2000, 19 (11) : 1392 - 1399
  • [3] RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
    Amato, Eliana
    Barbi, Stefano
    Fassan, Matteo
    Luchini, Claudio
    Vicentini, Caterina
    Brunelli, Matteo
    Malleo, Giuseppe
    Scarpa, Aldo
    Malpeli, Giorgio
    [J]. BMC CANCER, 2016, 16
  • [4] Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers
    Antony, Jane
    Zanini, Elisa
    Birtley, James R.
    Gabra, Hani
    Recchi, Chiara
    [J]. CANCER GENE THERAPY, 2021, 28 (1-2) : 18 - 26
  • [5] Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays
    Calhoun, Eric S.
    Hucl, Tomas
    Gallmeier, Eike
    West, Kristen M.
    Arking, Dan E.
    Maitra, Anirban
    Iacobuzio-Donahue, Christine A.
    Chakravarti, Aravinda
    Hruban, Ralph H.
    Kern, Scott E.
    [J]. CANCER RESEARCH, 2006, 66 (16) : 7920 - 7928
  • [6] Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
    Chauffaille, Maria de Lourdes L. F.
    Zalcberg, Ilana
    Barrero, Wolney Gois
    Bendit, Israel
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (03) : 261 - 268
  • [7] A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
    Chiappori, A. A.
    Kolevska, T.
    Spigel, D. R.
    Hager, S.
    Rarick, M.
    Gadgeel, S.
    Blais, N.
    Von Pawel, J.
    Hart, L.
    Reck, M.
    Bassett, E.
    Burington, B.
    Schiller, J. H.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (02) : 354 - 362
  • [8] Telomerase in the human organism
    Collins, K
    Mitchell, JR
    [J]. ONCOGENE, 2002, 21 (04) : 564 - 579
  • [9] FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
    Conroy, Thierry
    Desseigne, Francoise
    Ychou, Marc
    Bouche, Olivier
    Guimbaud, Rosine
    Becouarn, Yves
    Adenis, Antoine
    Raoul, Jean-Luc
    Gourgou-Bourgade, Sophie
    de la Fouchardiere, Christelle
    Bennouna, Jaafar
    Bachet, Jean-Baptiste
    Khemissa-Akouz, Faiza
    Pere-Verge, Denis
    Delbaldo, Catherine
    Assenat, Eric
    Chauffert, Bruno
    Michel, Pierre
    Montoto-Grillot, Christine
    Ducreux, Michel
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) : 1817 - 1825
  • [10] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929